India seeks 5 yr patent waiver for Covid diagnostics, therapeutics from WTO

India, Pakistan, South Africa, and five other countries have jointly proposed a five-year global patent waiver for Covid-19 diagnostics and therapeutics, according to a report by The Economic Times (ET). The submission to the World Trade Organization (WTO) was made on behalf of 65 members on Monday. In the submission, the members emphasised the ongoing importance of diagnostics and therapeutics in the comprehensive fight against the pandemic.
The submission aims to address intellectual property barriers, promote production, and enhance accessibility to critical Covid-19 tools. This would go a long way in enabling developing countries to expand and diversify production and increase accessibility without intellectual property (IP) barriers.
During the G20 Summit in India, Commerce and Industry Minister Piyush Goyal had also urged members to conduct timely discussions on the extension of patent waivers regarding the production and supply of Covid-19 diagnostics and therapeutics. Talks on therapeutic and diagnostics were raised by both India and South Africa during the G20 meets, under the purview of this waiver.
The request follows the US’ decision not to take a stance on extending the waiver, which currently applies only to Covid-19 vaccines. According to a report on Bloomberg, US President Biden reportedly stated that the administration needed more information on the matter, making it unlikely for the group to reach a consensus by the December 17 deadline. Moreover, European Union’s 27 members, the UK, Singapore, Switzerland, Japan and South Korea, all have opposed the waiver, claiming that there was not enough evidence to show IP rights were hampering the supply of treatments and tests of Covid-19.

Related Posts

  • Pharma
  • April 3, 2025
  • 57 views
Pharma tariff exemption: Temporary relief, but higher tariffs may be imposed later, warns analyst

US President Donald Trump has exempted pharmaceuticals from his reciprocal tariff plan announced on April 3. While he imposed a 26% tariff on other imports from India, this exemption has…

  • Pharma
  • April 3, 2025
  • 73 views
Fake pharmacy registration racket busted in Delhi, 47 held

New Delhi: The ACB busted a fake pharmacy registration racket and arrested 47 people, including a former employee of the Delhi Pharmacy Council , an official said on Wednesday. According…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Pharma tariff exemption: Temporary relief, but higher tariffs may be imposed later, warns analyst

Pharma tariff exemption: Temporary relief, but higher tariffs may be imposed later, warns analyst

Fake pharmacy registration racket busted in Delhi, 47 held

Fake pharmacy registration racket busted in Delhi, 47 held

11 substandard drugs in use in Telangana, finds Central Drugs Standard Control Organisation

11 substandard drugs in use in Telangana, finds Central Drugs Standard Control Organisation

Piramal Pharma’s Telangana unit starts production of general anesthesia drug Sevoflurane

Piramal Pharma’s Telangana unit starts production of general anesthesia drug Sevoflurane